Observational Study
Copyright ©The Author(s) 2022.
World J Cardiol. Dec 26, 2022; 14(12): 617-625
Published online Dec 26, 2022. doi: 10.4330/wjc.v14.i12.617
Table 1 Association of patients’ past medical conditions and conduction system disorder in coronavirus disease 2019 deceased patients
Medical condition
Patients without conduction system disorder (n = 317)
Patients with conduction system disorder (n = 108)
P value
SexFemale125 (73.1)46 (26.9)0.654
Male196 (75.1)65 (24.9)
Age, yr≤ 5046 (79.3)12 (20.7)0.147
51-6065 (81.3)15 (18.8)
61-7082 (75.2)27 (24.8)
> 70128 (69.2)57 (30.8)
IHDYes57 (71.3)23 (28.8)0.477
No260 (75.4)85 (24.6)
DMYes113 (72.0)44 (28.0)0.357
No204 (76.1)64 (23.9)
Renal diseaseYes42 (79.2)11 (20.8)0.501
No275 (73.9)97 (26.1)
Pulmonary diseaseYes23 (62.2)14 (37.8)0.078
No292 (75.6)94 (24.4)
HyperlipidemiaYes38 (70.4)16 (29.6)0.503
No279 (75.2)92 (24.8)
CKDYes19 (70.4)8 (29.6)0.648
No298 (74.9)100 (25.1)
HTNYes151 (72.9)56 (27.1)0.504
No165 (76.0)52 (24.0)
Table 2 Electrocardiographic parameters in conduction system disease in COVID-19 deceased patients
ECG parameters
Patients without conduction system disorder (n = 317)
Patients with conduction system disorder (n = 108)
Univariate OR (95%CI for OR)
P value
Adjusted1 odds ratio (95%CI for OR)
P value
Fragmented QRSYes53 (58.2)38 (41.8)2.63 (1.61-4.30)< 0.0012.27 (1.23, 4.16)0.008
No268 (78.6)73 (21.4)1-1-
ST-T changeYes125 (66.1)64 (33.9)2.14 (1.38-3.31)0.0011.81 (1.07, 3.08)0.030
No196 (80.7)47 (19.3)1-1-
RhythmSinus rhythm279 (76.2)87 (23.8)1-1-
AF34 (63.0)20 (37.0)1.89 (1.03-3.45)0.0391.70 (0.78-3.71)0.179
Others8 (66.7)4 (33.3)1.60 (0.47-5.45)0.4500.75 (0.15, 3.62)0.700
RateBradycardia (HR < 60)5 (55.6)4 (44.4)2.10 (0.55-8.01)0.2791.67 (0.31-9.06)0.554
Normal (60 < HR < 100)234 (72.4)89 (27.6)1-1-
Tachycardia (HR > 100)82 (82.0)18 (18.0)0.58 (0.33-1.02)0.0570.55 (0.27, 1.09)0.086
Axis deviationNormal283 (83.7)55 (16.3)1-1-
Left14 (48.3)15 (51.7)5.51 (2.52-12.07)< 0.0013.74 (1.50-9.33)0.005
Right24 (36.9)41 (63.1)8.79 (4.92-15.71)< 0.0017.67 (3.95-14.88)< 0.001
QTc 1< 500211 (75.1)70 (24.9)1-1-
> 500110 (73.3)40 (26.7)1.10 (0.70-1.72)0.6910.94 (0.53, 1.66)0.819
QTc 2Male ≤ 440 and female ≤ 460300 (74.4)103 (25.6)1-Not included due to collinearity with the above variable
Male > 440 and female > 46021 (75.0)9 (25.0)0.97 (0.40-2.35)0.948
QTd< 4045 (81.8)10 (18.2)1-1-
≥ 40276 (73.2)101 (26.8)1.65 (0.80-3.39)0.1761.42 (0.58-3.47)0.446
J waveYes13 (68.4)6 (31.6)1.35 (0.50-3.65)0.5500.98 (0.28-3.49)0.978
No308 (74.6)105 (25.4)1-1-
U waveYes32 (71.1)13 (28.9)1.20 (0.60-2.38)0.6051.10 (0.47, 2.63)0.815
No289 (74.7)98 (25.3)1-1-
Early repolarizationYes15 (83.3)108 (26.1)0.57 (0.16-2.00)0.3771.00 (0.26-3.93)0.998
No306 (73.9)108 (26.1)1-1-
T slope< 3012 (75.0)4 (25.0)1-1-
30-60302 (74.6)103 (25.4)1.02 (0.32-3.24)0.9690.79 (0.21, 2.98)0.728
> 607 (63.6)4 (36.4)1.71 (0.32-9.11)0.5271.87 (0.249-14.01)0.551
S1Q3T3Yes38 (61.3)24 (38.7)2.05 (1.17-3.61)0.0121.83 (0.92-3.64)0.086
No283 (76.5)87 (23.5)1-1-
Low voltage QRSYes42 (85.7)7 (14.3)0.45 (0.20-1.03)0.0580.38 (0.14-1.05)0.063
No279 (72.8)104 (27.2)1-1-
PRPYes121 (68.4)56 (31.6)1.68 (1.09-2.60)0.0191.32 (0.77-2.26)0.317
No200 (78.4)55 (21.6)1-1-